This page is part of the FHIR Specification (v4.1.0: Release 4B Ballot #1). The current version which supercedes this version is 5.0.0. For a full list of available versions, see the Directory of published versions . Page versions: R5 R4B R4 R3
Pharmacy Work Group | Maturity Level: N/A | Standards Status: Informative | Compartments: Device, Encounter, Patient, Practitioner, RelatedPerson |
This is the narrative for the resource. See also the XML, JSON or Turtle format. This example conforms to the profile MedicationAdministration.
Generated Narrative
status: completed
form: Injection emulsion
ingredient
item: Clinimix 4.25/10 sulfite-free (4.25% Amino Acid in 10% Dextrose) Injection, 1000ml
ingredient
item: TPN Electrolytes SODIUM CHLORIDE, CALCIUM CHLORIDE, POTASSIUM CHLORIDE, MAGNESIUM CHLORIDE, and SODIUM ACETATE ANHYDROUS | INJECTION, SOLUTION, CONCENTRATE | 321 mg/20mL, 331 mg/20mL, 1491 mg/20mL, 508 mg/20mL, 2420 mg/20mL
ingredient
item: Intralipid 20% IV Fat Emulsion
Batches
- LotNumber ExpirationDate * 123455 2016-07-09
effective: 16 Jan. 2015, 8:03:00 am --> 16 Jan. 2015, 12:03:00 pm
device: Generated Summary: id: 12345; status: active
- | Text | Site | Route | Method | Dose | Rate[x] |
* | 1000mL infused at 50ml/hour for 4 hours - hung at 2200 hours | Structure of ligament of left superior vena cava | Intravenous | PICC line | 1000 mL | 50 mL/1 h |
Usage note: every effort has been made to ensure that the examples are correct and useful, but they are not a normative part of the specification.